SEATTLE--(BUSINESS WIRE)--Reverba, a global health engagement company specializing in innovative and compliant patient engagement and medical communication solutions for biopharmaceutical companies, today announced the appointment of Scott Wolf as the company's Chief Growth Officer (CGO). In his new role, Wolf will lead strategic growth initiatives focusing on expanding Reverba’s market reach, driving business development, and enhancing customer relationships.

西雅图--（商业新闻短讯）--Reverba是一家专门为生物制药公司提供创新和合规的患者参与和医疗通信解决方案的全球健康参与公司，今天宣布任命ScottWolf为公司首席增长官（CGO）。在新的岗位上，Wolf将领导战略增长计划，重点是扩大Reverba的市场覆盖范围，推动业务发展，并加强客户关系。

His leadership will further solidify Reverba’s position as a pioneer in delivering cutting-edge engagement strategies across the biopharma industry..

他的领导将进一步巩固Reverba在生物制药行业提供尖端参与战略方面的先驱地位。。

“We are delighted to welcome Scott to our leadership team. His extensive experience in growth strategies and business development makes him the perfect fit for this role,” said Cheryl Lubbert, CEO of Reverba. “Scott’s passion for customer engagement aligns seamlessly with our mission, and I’m confident his leadership will accelerate our growth and help us achieve our ambitious goals.”.

Reverba首席执行官谢丽尔·卢伯特（CherylLubbert）表示：“我们很高兴欢迎斯科特加入我们的领导团队。他在增长战略和业务发展方面的丰富经验使他非常适合担任这一角色。”。“斯科特对客户参与的热情与我们的使命完美契合，我相信他的领导将加速我们的增长，帮助我们实现雄心勃勃的目标。”。

Wolf brings over 20 years of experience in business development, sales, and operational leadership across a range of tech, business-to-business, and consumer industries.

沃尔夫在一系列技术、企业对企业和消费行业的业务开发、销售和运营领导方面拥有20多年的经验。

“I am thrilled to join the Reverba team at such an exciting time of innovation and expansion,” said Scott Wolf, Chief Growth Officer of Reverba. “Reverba's commitment to empowering health consumers through unique engagement solutions resonates deeply with me, and I look forward to collaborating with the team to build on this momentum and achieve new levels of success.”.

Reverba首席增长官斯科特·沃尔夫（ScottWolf）表示：“在如此激动人心的创新和扩张时期，我很高兴加入Reverba团队。”。“Reverba致力于通过独特的参与解决方案增强健康消费者的能力，我对此产生了深刻的共鸣，我期待着与团队合作，在这种势头的基础上再接再厉，取得新的成功。”。

Wolf joins Reverba from Wolf Media Group, where he was Founder & CEO. Prior to Wolf Media Group, he held the position of Chief Revenue Officer (CRO) for health and wellness website Everyday Health. Over the course of his 10-year career there, Scott grew his division from three to more than 150 employees and grew revenue from $2 million to $200 million.

沃尔夫是沃尔夫传媒集团（WolfMedia Group）创始人兼首席执行官，他加入了里弗巴（Reverba）。在加入Wolf Media Group之前，他曾担任健康与健康网站Daily health的首席收入官（CRO）。在那里的10年职业生涯中，斯科特将其部门从三名员工增加到150多名员工，收入从200万美元增加到2亿美元。

As CRO, Scott was a fundamental part of Everyday Health’s senior executive team, responsible for launching the website and taking the company public, completing an IPO in 2014..

作为首席风险官，斯科特是日常健康高级管理团队的重要组成部分，负责启动网站并将公司上市，并于2014年完成IPO。。

Prior to his time at Everyday Health, Wolf held executive positions at major technology and publishing companies, including CMP Media, Muzak, Vivendi Universal Music Internet Group, and Bidtellect, where he specialized in scaling organizational revenue into the multi-millions.

在从事日常健康工作之前，沃尔夫曾在主要技术和出版公司担任高管职位，包括CMP Media、Muzak、Vivendi Universal Music Internet Group和Bidtellect，他专门负责将组织收入扩大到数百万美元。

Wolf holds an MBA degree from the NYU Stern School of Business and graduated with honors from the University of Pennsylvania.

沃尔夫拥有纽约大学斯特恩商学院的MBA学位，并以优异成绩毕业于宾夕法尼亚大学。

About Reverba

关于Reverba

Reverba is a global health engagement company that provides solutions to empower the biopharmaceutical industry to build connections with consumers and better meet the needs of patients through innovative technology and patient-centric approaches from discovery through commercialization.

Reverba是一家全球健康参与公司，提供解决方案，使生物制药行业能够通过创新技术和以患者为中心的方法，从发现到商业化，与消费者建立联系，更好地满足患者的需求。

Recently, Reverba expanded its global footprint through the acquisition of Six Degrees Medical, a leading medical communications agency specializing in medical affairs and scientific engagement. This strategic acquisition enhances Reverba’s ability to deliver comprehensive solutions in clinical trials, medical affairs, patient engagement, and scientific communications, further solidifying its leadership in the industry..

。此次战略性收购增强了Reverba在临床试验、医疗事务、患者参与和科学交流方面提供全面解决方案的能力，进一步巩固了其在行业中的领先地位。。

For more than 20 years, Reverba has incorporated compliance throughout its technology platforms and patient engagement solutions, maintaining SOC 2 Type II certification for the highest level of security. Formed from the mergers of Health Advocacy Strategies, Patient Health Perspectives, and Health Perspectives Group, the company rebranded as Reverba in 2021.

。该公司由健康倡导战略、患者健康视角和健康视角集团合并而成，于2021年更名为Reverba。

Health Stories Project, a wholly owned subsidiary of Reverba, is a sharing community about personal health experiences, participation in clinical trials, and other activities..

健康故事项目是Reverba的全资子公司，是一个关于个人健康经历、参与临床试验和其他活动的共享社区。。

For more information, visit reverba.com or contact connect@reverba.com.

有关更多信息，请访问reverba.com或联系connect@reverba.com.